FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy (Q72396841)
Jump to navigation
Jump to search
scientific article published on 01 January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy |
scientific article published on 01 January 1994 |
Statements
FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy (English)
G Catimel
F Chauvin
J P Guastalla
P Rebattu
P Biron